Abstract
Due to immune impairment and lymphocyte enrichment of oral squamous cell carcinoma (OSCC), anti-PD-1/PD-L1 therapy is regarded as a potential treatmen......
小提示:本篇文献需要登录阅读全文,点击跳转登录